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FOREWORD
Our organisations – IOGT-NTO and the Swedish Society of Medicine – are proud to present the 
second in our series of reports entitled “Alcohol and Society”. The concept behind the report is, 
in many respects, unique. We brought together an international group of leading alcohol rese-
archers and gave them a task. We asked them, on the basis of the theme that we had identified 
as being both important and topical, namely low-dose alcohol consumption, to review the latest 
global research in the field, to describe the scientific status, and then to draw conclusions on 
measures tailored for Sweden and the rest of the Nordic region.
Focusing on low-dose alcohol consumption was, for us, as obvious as it was important. We 
live in a world where the media switch rapidly, and on a daily basis, between reporting on the 
supposed health benefits of a glass of wine and issuing warnings about the self-same thing. No 
other area in the field of alcohol research and alcohol-related media reporting sends out as many 
mixed signals as this one, and we accordingly asked the researchers to take a comprehensive 
view of the situation, in order both to analyse the facts and also explain why the conclusions 
diverge so widely. The results are both unique and interesting. It is our hope that they will 
provide greater clarity in the Swedish debate and in the media reporting on low-dose alcohol 
consumption.
We have also, in addition to our main article, interviewed representatives of several of the 
leading media organisations in Sweden, asking them how they see their role, how they evaluate 
research findings, and what their position is on contradictory information about the health-re-
lated effects of alcohol. And finally, at the end of the report, we touch, as we did last year, on 
some of the latest alcohol research findings in other areas.
The Swedish version of the report has been written with accessibility in mind. The research it 
contains is presented in a way that makes it easily accessible by anyone with an interest in public 
health issues. For a more in-depth view, there is an English language version that also presents 
the references for the main article. Both language versions of the report are available on our 
respective websites at the URLs shown on the back cover.
We hope that you will find this report absorbing and that it provides you with valuable informa-
tion on the latest findings in the field of alcohol research. This is the second year that we have 
produced an “Alcohol and Society” report and we look forward to presenting it for many more 
years to come. 
Anna Carlstedt   Kerstin Nilsson
Chair, IOGT-NTO  Chair, The Swedish Society of Medicine
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EVIDENCE ABOUT HEALTH 
EFFECTS OF “MODERATE” 
ALCOHOL CONSUMPTION:
REASONS FOR SCEPTICISM AND PUBLIC HEALTH 
IMPLICATIONS 
By Sven Andréasson, Tanya Chikritzhs, Frida Dangardt, Harold Holder,  
Timothy Naimi and Tim Stockwell
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EXECUTIVE SUMMARY 
This report summarizes and examines the scientific evidence regarding the health 
effects of “moderate” (i.e., low-dose) alcohol consumption, and discusses the impli-
cations of this research for clinical practice, low-risk drinking guidelines, and alcohol 
policy development. 
The existing evidence finding cardiovascular benefits from low-dose alcohol consumption 
is weak, and emerging evidence suggests that these protective effects are spurious (i.e., 
do not exist, or are harmful). The view that alcohol confers health benefits is therefore 
even less of a valid counter-argument against the adoption of effective alcohol control 
policies (e.g., those which reduce alcohol’s availability and affordability).
• Although alcohol consumption is a leading cause of preventable death and social problems worldwide, previous 
studies often find an association between low-dose consumption and a reduced risk of cardiovascular (CVD) 
disease. Despite shortcomings in the science, this information has been promoted extensively, used to argue 
against the adoption of policies to reduce excessive drinking and led some doctors to advise patients to drink for 
better health.
• However, there have been no “randomised” studies of low-dose alcohol consumption and any disease or death 
outcomes to confirm findings from non-randomised studies. Randomised studies are the gold standard used 
to determine the safety and effectiveness of medical drugs. There are more than 10 recent examples in which 
conclusions from observational studies were contradicted later by randomised studies (e.g. hormone replacement 
therapy for the reduction of heart disease in women).
• Laboratory studies have indicated that low-dose alcohol consumption reduces some biological markers of heart 
disease. However, more recent and sophisticated studies have refuted some markers as causal factors of CVD 
mortality (e.g., HDL cholesterol). Further, low-dose alcohol consumption is associated with physiological effects 
that should increase CVD mortality, such as increased blood pressure.
• There are many methodological problems with non-randomised (i.e., observational) studies. Most important 
among these are confounding and misclassification. Non-drinkers and moderate drinkers differ in many ways 
besides alcohol consumption. The majority of observational studies classify people as abstainers who have cut 
down or quit drinking, many of whom have health problems. This makes moderate drinkers appear to be health- 
ier than they really are.
• The observation of apparent health benefits from moderate drinking has also been made for a number of health 
conditions for which there is no plausible physiological basis (e.g., liver cirrhosis, improved childhood develop-
ment, cancers, hip fractures, deafness and the common cold), suggesting that protective associations with other 
conditions may not exist.
• A large international genetic (Mendelian) randomisation study found that having a genetic disposition that causes 
less drinking is associated with a significantly reduced risk of coronary disease, even among those who consume 
modest amounts of alcohol.
• Studies of populations that have experienced reductions in total alcohol consumption do not find any evidence of 
increased rates of cardiovascular disease.
• Even assuming cardiovascular benefits from moderate drinking are real, the WHO estimates are that alcohol 
causes far more death and disability than it prevents. Further, if real, the optimal mortality benefits apply at 
very low levels (maximally half a drink per day for women, and less than one drink per day for men) and increase 
thereafter. 
• Physician advice to patients and low-risk drinking guidelines should focus on reducing consumption to safer 
levels among current drinkers, and should discourage drinking initiation or increased consumption on the basis 
of health-related considerations
• From the public health perspective, governments should adopt and strengthen effective alcohol control policies to 
reduce alcohol-related deaths, social problems and economic costs. The growing scientific scepticism regarding 
evidence about the health effects of low-dose alcohol consumption should further enhance their rationale for 
doing so.
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SECTION 1. INTRODUCTION: 
“MODERATE” (LOW-DOSE) 
ALCOHOL CONSUMPTION
Is alcohol good for health? Over the past 40 years a 
growing list of epidemiological studies suggest that 
when drunk in “moderation” alcohol is associated with 
a reduced risk of death from all causes and, in parti-
cular, a significantly reduced risk of cardiovascular 
disease (CVD) 1 and diabetes.2 
On the other hand, a longstan-
ding and much larger literature 
has made it clear that heavy 
drinking causes a multitude 
of medical harms.3, 4 The list 
of alcohol related medical 
conditions has grown over the 
years and now includes more 
than 60 major types of health 
condition, reflecting that the 
toxicity of alcohol affects 
all tissues and organs of the 
human body. Globally, about 
3.3 million deaths or 5.9% of 
all deaths were estimated to be 
caused by alcohol in 2012. This 
figure is a net figure estimated 
after the assumed beneficial 
effects of low-dose alcohol 
consumption have been taken into account.
Although alcohol has toxic and carcinogenic properties, 
this does not necessarily preclude the possibility of 
health benefits in low doses, as is the case with a large 
number of pharmaceuticals. A number of mechanisms 
whereby alcohol could exert a beneficial effect have 
been proposed, including its effect on blood lipids and 
blood clotting. An important observation, however, 
is that the literature on beneficial effects primarily 
addresses chronic disease while the literature on 
alcohol’s detrimental effects to a large extent involve 
acute effects such as accidents and violence. Even low 
doses of alcohol consumption increases the risk for 
acute harm, e.g. from traffic injuries. Of the traffic 
deaths in Sweden, 21% are caused by drivers under the 
influence of alcohol.5 Low-dose alcohol also increases 
the risk for several chronic conditions like cancer and 
hypertension. 
Nevertheless, the notion of beneficial effects from 
low-dose or “moderate” drinking has had a huge impact 
in the alcohol field, with implications for medical 
practitioners as well as for policy makers. Almost every 
time a new study suggesting health benefits has been 
published, these results have been given good coverage 
in the media and this appears to have shaped attitudes 
in the general population regarding the potential risks 
versus benefits from drinking alcohol. For many prac-
titioners, the message from researchers about positive 
health effects has caused uncertainty about what advice 
is appropriate to provide to patients. Even if most 
practitioners recognize the hazards related to alcohol, 
they may be hesitant to convey a message that is too 
restrictive as this might deny their patients a positive 
health effect. In some cases moderate drinking may be 
recommended by physicians, even for abstainers. 
For policy makers, the question arises as to how to 
regulate a dangerous commodity where research also 
suggests positive health effects when this commodity 
is used in moderation. The message from the alcohol 
industry is clear: alcohol policies should focus on the 
minority in the population with 
problem drinking, offering these 
individuals treatment, and leave 
the rest, the majority who are 
moderate drinkers, alone. This 
conflicts with the conclusions from 
alcohol policy research, where 
policies that reduce total consump-
tion through restrictions on the 
economic and physical availability 
have been shown to be more effec-
tive in reducing alcohol problems. 
A challenge to research- 
ers and policy makers alike is 
the fact that in reality low-dose 
alcohol consumption does not 
exist in isolation. There is a strong 
link between the prevalence of 
moderate drinking and excessive 
drinking, where an increase in the 
former is followed by the latter. Low-dose consumption 
is not something that we can ”choose” as a preferred 
drinking option for populations, and among developed 
countries a substantial fraction of drinkers consume 
alcohol in ways that clearly increase the risk of health 
and social consequences for themselves and others.
The notion of beneficial effects on CVD mortality from 
moderate drinking therefore is crucial. One important 
question is whether the conclusions about these effects 
from the published literature are in fact correct. Over 
the past decade a number of doubts have been raised 
regarding the methodology underlying the studies 
informing this evidence base, which is comprised 
entirely of non-randomised studies. It is increasingly 
being understood that a large part of the beneficial 
effect of alcohol found in many studies is likely due 
to a number of methodological limitations, which are 
discussed below. It is also likely that moderate alcohol 
use is an indicator of positive health and social well-
being. The studies that find beneficial effects all involve 
asking people questions about their drinking patterns 
which are then matched with their personal health 
outcomes. Even if large in number, such studies (often 
called observational studies) all share the methodo-
logical weaknesses that are inherent in this type of 
research, chief among these is a lack of randomisation 
of exposure. Critically, there are no experimental 
studies in which participants are randomly assigned 
to groups where alcohol is consumed or not consumed 
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(the control group). Such experimental studies, i.e., 
randomised controlled studies, are normally required 
in medicine as a basis for testing an intervention such 
as a pharmaceutical drug.
SECTION 2. HARMS FROM 
ALCOHOL CONSUMPTION
Alcohol is a toxic substance with psychoactive proper-
ties and the capability to cause dependence among 
users along with a variety of other health conditions. 
As a result, globally, about 3.3 million net deaths were 
estimated to be caused by alcohol in 2012 (this esti-
mate took into account the assumed beneficial effect 
of low-dose alcohol consumption).6 The estimated 
burden of alcohol-related death, disease and disability 
has increased in the last decades in WHO sponsored 
international studies. In 2010, out of more than 60 risk 
factors, alcohol was ranked as the fifth leading cause of 
death and disability globally, up from eighth place in 
1990.7
For people aged 15–49 years, alcohol is the leading 
health-related risk factor worldwide, followed by 
tobacco smoking, high blood pressure and high body-
mass index.8 This is greater than, for example, the 
proportion of deaths from HIV/AIDS (2.8%), violence 
(0.9%) or tuberculosis (1.7%). Not all of the conditions 
linked to alcohol are included in these estimates.9 
The estimated negative effect on the global burden of 
disease from alcohol is more than 30 times as large as 
the beneficial effect.10 
The proportion of alcohol-attributable burden of 
disease is highest in the WHO European Region  
(12.8 %). In high-income countries within Europe,  
such as Sweden, there is a much higher alcohol-attribu-
table disease burden compared to alcohol-attributable 
deaths because of the disabling impact of alcohol use 
disorders.11
2.1. Harms from Chronic 
Health Conditions
Alcohol produces a large chronic 
disease burden as a necessary cause 
of a large number of specific condi-
tions such as alcoholic liver cirrho- 
sis and fetal alcohol syndrome. In 
addition it is a contributing causal 
factor in a large number of other 
disease conditions, such as cancers, 
cardiovascular disease, and infectious 
disease.12
Alcohol has been classified as carcinogenic to humans 
since 1988 by the WHO International Agency for 
Research on Cancer, IARC.13 In 2007 two new reviews 
on alcohol and cancer were published, one by IARC and 
one by the World Cancer Research Fund / American 
Institute for Cancer Research. Both reviews concluded 
that alcohol not only caused malignant tumours of the 
oral cavity, pharynx, larynx, oesophagus and liver, 
conditions that were linked to alcohol already in the 
1988 report, but that alcohol also was a cause for colo-
rectal and female breast cancer.14, 15 As breast cancer 
and colorectal cancer are two of the most common 
cancers worldwide, the proportion of cancers attri-
butable to alcohol consumption became higher than 
previously estimated.
The cancer risk from alcohol increases with the amount 
of ethanol drunk, in the absence of any threshold 
below which no effect is evident.16, 17 For example, the 
relative risk of breast cancer is estimated to increase 
with increasing alcohol intake by about 10% per 10 g 
per day.18 Among other disease categories, alcohol is 
directly responsible for between 4% and 25% of the 
disease burden related to specific cancers worldwide. 
Alcohol consumption also contributes to about 10% 
of the disease burden due to tuberculosis, epilepsy, 
haemorrhagic stroke and hypertensive heart disease  
in the world.
For the majority of diseases linked to alcohol the 
risk increases with increasing consumption without 
a threshold under which there is no increased risk.19 
A meta-analysis from 2004 20 concluded e.g. that the 
risk of hypertension increased by 43 per cent for a 
consumption of two standard drinks per day. For the 
same level of consumption the risk for haemorrhagic 
stroke increased 19 per cent, and the risk for liver 
cirrhosis was almost three times greater, compared to 
non-drinkers. 
2.2 Harms from Acute Health 
Conditions
The effects of alcohol consumption are not only con- 
fined to chronic diseases arising from long-term expo-
sure but also increase the risk for 
acute conditions which typically occur 
from acute intoxication with alcohol. 
Alcohol is a psychoactive substance 
which produces specific in-the-mo-
ment impairment for hand-eye coor-
dination, depth perception, general 
judgment, and reflex response. As 
a result, alcohol is involved in a 
number of acute harms even at low 
dosage which require specific skills 
and responses including operating 
automobiles, boats, machinery, and 
other complex tasks. A recent German 
experiment found that low-dose 
alcohol had a greater impairment on 
attention performance for adolescents compared to 
adults on the same test.21 These results suggest that 
low-dose drinking by youth can result in more impair-
ment in complex tasks like driving or operating machi-
nery than for adults. A significant number of personal 
injuries and violent events are associated with 
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alcohol impairment. The impairment of the drinker 
also has serious social and economic consequences for 
individuals other than the drinker, e.g. assaults, traffic 
crashes, property damage, domestic violence, and child 
neglect or abuse.
That drinking to intoxication increases risks for inju-
ries is well-known, however, low-dose consumption 
also increases the risk for several types of injuries. 
In Sweden, like most developed countries in which 
driving is a major mode of travel, alcohol-impaired 
drivers cause a substantial number of traffic deaths.22 
Experiments with alcohol consumption in connection 
with driving have shown that a BAC of 0.03% signifi-
cantly increases stop distance and the ability to avoid 
obstacles.23 A review in 2004 of studies from the past 
fifty years came to the conclusion that there is no 
evidence of a threshold below which impairment do not 
occur and that significant impairment occurs at very 
low BAC, below 0.02 %.24 
Low-dose alcohol consumption also increases the risk 
for injuries other than those that are traffic-related. 
A study from a Swiss hospital emergency department 
of all types of injuries found that of alcohol related 
injuries, acute low-dose consumption (one unit or fewer 
of alcohol for women and two units or fewer for men) 
was related to 50 per cent of transport injuries, 44 per 
cent of falls, 50 per cent of exposure to forces and other 
events and 24 per cent of injuries from interpersonal 
violence. As percentage of all injuries, low-dose alcohol 
consumption was related to 21.5 per cent of transport 
injuries, 22 per cent of falls, 21 per cent of exposure to 
forces and other events and 16 per cent of injuries from 
interpersonal violence.25 A recent Norwegian study, 
found that, the risk of an alcohol-related injury incre-
ases linearly with frequency of binge drinking.26 
While alcohol has been often linked to interpersonal 
violence in naturalistic observational studies, there are 
recent laboratory experiments which suggest a linear 
dose-response relationship up to a high dose of 1.0g/kg 
relationship between alcohol and aggression.27
SECTION 3. REASONS FOR 
SCEPTICISM ABOUT THE 
EFFECTS OF LOW-DOSE 
ALCOHOL
3.1. Limitations of existing observa-
tional studies, lack of randomised 
trials
Most of the studies that provide evidence for health 
benefits associated with moderate drinking involve the 
observation of a group of individuals followed up over 
a number of years. There are no control groups as in an 
experimental study rather, people are compared accor-
ding to various behaviours such as their diet, substance 
use and exercise habits and/or on the basis of charac-
teristics such as gender, socio-economic status and 
ethnicity. Such “observational studies” on their own 
can identify associations between potential risk factors 
and disease outcomes over time but are not generally 
sufficient to prove causation. Thus, in studies of alcohol 
consumption and disease, observed associations can 
be caused by a variety of other lifestyle, psychosocial, 
genetic and physiological factors each of which may be 
independently associated with alcohol consumption in 
the population being studied. The strongest scientific 
evidence for causal relationships is generally accepted 
to be from randomised controlled trials (RCT), where 
potential confounding factors can be reduced by rando-
mising participant exposure to a potential factor like 
drinking alcohol at a particular level and then compa-
ring them to a control group who are not exposed to 
that factor. 
In alcohol research, however, there has not been any 
RCT involving alcohol that assesses a morbidity or 
mortality outcome/endpoint. One reason for this lack 
of RCTs is that there are substantial practical and 
possibly even ethical problems with randomising 
individuals to drink or not drink over a period of many 
years. Regardless, this represents a major limitation 
in the evidence base about the effects of low-dose 
alcohol consumption. Other sources of evidence for the 
existence of causal relationships will be discussed here 
including: (i) the use of laboratory experiments to iden-
tify the impacts of low-doses of alcohol on biological 
markers known to be risk factors for disease; (ii) the 
study of the impact of random genetic variations in the 
population; and, (iii) the impact on disease outcomes 
of population level changes in exposure to alcohol 
consumption.
Although many observational studies have found 
a J-shaped curve in which people with low average 
alcohol consumption have lower mortality from all 
causes than people who do not drink at all, it is impor-
tant to remember that even a large number of consis-
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tent observational studies showing similar outcomes 
can be consistently wrong. Indeed, findings from even 
well done observational studies with plausible biologic 
hypotheses may differ from those of randomised 
controlled trials, and these differences are believed to 
be partly due to residual or unmeasured confounding.28
Considering the much wider literature on the inter-
pretation of observational studies examining the 
psychosocial and behavioural risk factors for diseases, 
it is most often found that frequently observed associ-
ations are confirmed in randomised controlled trials.29 
However, this is not always the case and some notable 
exceptions have been recorded in which multiple 
observational studies appear to have been biased to 
produce misleading conclusions. For example, many 
observational studies suggested that increased beta 
carotene intake might be associated with reductions 
in CVD and cancer, that hormone replacement therapy 
and vitamin E supplementation were associated with 
reductions in CVD and dementia, and that Chlamydia 
infection was associated with atherosclerotic heart 
disease. However, beta-carotene, vitamin E, hormone 
replacement therapy, and antimicrobial treatment for 
Chlamydia were found to be ineffective when subjected 
to randomised trials.30, 31, 32, 33, 34 Hormone replacement 
therapy offers a particularly striking example, since 
multiple well-done observational studies by eminent 
epidemiologists suggested 40% reductions in coronary 
heart disease, and no effect was found when RCTs were 
conducted. 
Recently statins, which have been used in medicines to 
lower cholesterol levels used to prevent cardiovascular 
disease, have been added to this list. Observational 
data have shown statins to have a beneficial effect 
on acute respiratory distress syndrome and chronic 
obstructive pulmonary disease but this has now been 
disproved in randomised controlled trials.35 Another 
recent example is the use of bisphosphonates associated 
with a substantially decreased risk of breast cancer 
found in several observational studies. In the RCTs, 
contrary results were found, showing 3 to 4 years of 
bisphosphonate treatment did not decrease the risk of 
invasive postmenopausal breast cancer.36 
While it may be challenging to conduct population 
level trials in which individuals are randomised into 
drinking alcohol or abstaining over long periods, two 
other main approaches have been employed to investi-
gate whether the observed health benefits are causally 
related to moderate alcohol consumption. One has been 
to conduct laboratory experiments over relatively short 
time periods in which individuals are randomised to 
receive measured doses of alcohol or to abstain under 
controlled conditions. Biological measures believed to 
be indicative of cardiac health and functioning have 
been used as the main outcome measures. Another 
more recent approach is known as Mendelian rando-
misation in which the observed effects of genetic 
variations between individuals can be considered 
equivalent to a randomised controlled trial. In the field 
of alcohol and health studies, this has become possible 
through the identification of a genetic variation thought 
to be uniquely associated with abstinence or greatly 
reduced alcohol consumption. The results of these 
studies will be summarised below along with a number 
of other methodological concerns which need to be 
considered when interpreting the large and apparently 
compelling literature of studies connecting improved 
health outcomes with moderate or low volume alcohol 
consumption.
Confounding
Confounding (i.e., when a factor that is associated with 
both the exposure and the outcome, but when the factor 
is not in the causal pathway between them) is an impor-
tant threat to validity for observational studies that can 
lead to erroneous associations between an exposure 
(i.e., low-dose alcohol intake) and disease outcomes 
(e.g., cardiovascular disease). If the health of moderate 
drinkers is to be compared to that of non-drinkers in 
order to determine the effect of alcohol, a meaningful 
comparison would require that the two groups be 
generally similar in most respects other than alcohol 
consumption. However, evidence demonstrates that 
confounding is a serious problem in studies of alcohol 
consumption and cardiovascular disease conducted 
among Western populations. Specifically, studies from 
Europe and North America find that among non-drin-
kers most traditional cardiovascular risk factors are 
more prevalent and intense among non-drinkers 
compared to those who drink moderately, particularly 
those who drink small amounts frequently.37, 38, 39, 40, 41, 
42 Assuming that the differential distribution of many 
of these factors is not the result of alcohol consumption 
(or lack thereof), these risk factors represent poten
OBSERVED HEALTH BENEFITS 
CONTRADICTED BY CONTROLLED STUDIES
Hypothesis
Beta carotene protective  
for cancer and CVD
Vitamin E protective for 
dementia and CVD
Hormone replacement 
therapy protective for 
coronary heart disease
Bisphosphonates protective 
for post menopausal breast 
cancer
Omega 3 fatty acids protec-
tive for diabetes
Observational 
Yes
Yes
Yes
Yes
Yes
Randomised  
controlled trials
No
No
No
No
No
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tial confounders that could make low-dose alcohol 
consumption appear to be protective for cardiovascular 
disease.
While most analyses try to adjust for these differences, 
studies do not always collect information about relevant 
potential confounders, including “traditional” cardiac 
risk factors. 43 However, even in well-controlled studies, 
the disproportionate number 
and intensity of risk factors 
associated with non-drinking 
status means that the threat of 
residual confounding is high 
(i.e. confounding that persists 
even after attempts to control 
for it in analyses) and likely 
to bias studies in favour of 
moderate drinkers such that 
they appear in better health. 
Furthermore, those with more 
risk factors have more possible 
combinations of risk factors 
that could be synergistic in 
terms of risk. To the extent 
that synergistic risk (i.e., independent additional risk 
beyond the sum of independent risks) is not captured 
in observational studies, this would again bias studies 
in favour of moderate drinkers. Finally, because 
coronary heart disease risk factors tend to cluster in 
certain individuals and populations, it is plausible that 
unknown or unmeasured confounders may be more 
prevalent among non-drinkers than those with low 
average alcohol consumption, which could again favour 
apparent reduced risk among moderate drinkers. 
In addition to the distribution of traditional cardiac 
risk factors, low-dose alcohol consumption appears to 
be a marker of “non-traditional” socio-economic factors 
such as affluence, leisure, education, mental health, 
and dentition.44, 45 These non-traditional risk factors 
are major determinants of mortality, and few of these 
factors are plausibly caused by alcohol consumption 
itself.46 Since there is no likely causal relationship 
between, for example, drinking alcohol and having 
previously achieved higher educational attainment, it 
seems likely that moderate drinking is merely a reflec-
tion or result of prosperity and wellness, rather than its 
genesis. This makes non-traditional risk factors a rich 
source of confounding that could distort the apparent 
relationship between alcohol consumption and health 
outcomes. Unfortunately, few surveys that include 
alcohol consumption also include questions about many 
of these non-traditional risk factors, which make it 
difficult or impossible to account for them statistically.
Findings from Sweden are consistent with the notion 
that non-drinkers have more risk factors and worse 
health at baseline. A study of Swedish women found 
that abstainers and occasional drinkers had lower 
levels of education, more use of psychotropic drugs, 
and were more likely to receive a disability pension.47 
In terms of mortality, non-drinkers had a significantly 
increased risk for death compared to moderate drin-
kers, but after accounting for household composi-
tion, level of education, employment, social network, 
smoking, regular medical control for a physical or 
mental disease, hypertension and diabetes, nondrin-
king was no longer a risk factor for death. The authors 
concluded that this underlines the importance of 
including health status at base-line when prospecti-
vely studying the association between alcohol use and 
mortality, otherwise moderate 
alcohol consumption may appear 
more beneficial than is the case.48
Among Swedish abstainers, two 
groups can be distinguished: 
those who abstain for reasons of 
principle (e.g., religion, healthy 
lifestyle, social solidarity, etc.) 
and those whose abstinence is 
related to economic hardship, 
social isolation or health.49 A 
Swedish conscripts study found 
that nondrinking conscripts 
deviated from moderate drinkers 
on a number of psychosocial 
measures. The study population consisted of young 
men, mostly aged 18 to 19 years. Abstainers compared 
with moderate drinkers had lower emotional control, 
felt more insecure in the company of others, reported 
being less popular in school, had fewer friends, and 
were more anxious. U-shaped curves were produced 
when indicators of poor sociability were depicted in 
relation to level of alcohol consumption. Abstainers 
also had more psychopathology than moderate 
consumers.50
Because of the heterogeneity of non-drinkers, it may be 
most relevant to examine the risk of death among those 
who abstain for religious or family reasons rather than 
for reasons related to poor health or economic depriva-
tion. A U.S. national survey of more than 40 000 adults 
aged 21 years or greater obtained reasons for not drin-
king among abstainers. People stating that the main 
reason for not drinking was “have responsibility to my 
family”, “religious or moral reasons” or “don’t socia-
lize very much” had an equal risk of death as current 
drinkers with a consumption of less than one drink per 
day. People stating reasons as “do not like alcohol”, “am 
an alcoholic”, “thought I might become an alcoholic”, 
“medical or health reasons” and “costs too much” had a 
higher risk of death.51, 52
Corroborating concerns about confounding, there are 
several diseases for which low-dose consumption has 
an implausible protective association for which convin-
cing biological mechanisms have not been proposed. 
These include protective effects of low-dose alcohol 
for deafness, hip fracture, asthma, the common cold, 
and overweight.53 Moderate consumers of alcohol have 
even been shown to have lower risks for conditions like 
alcoholic liver cirrhosis54 and cancer55 than non-drin-
kers, despite the fact that alcohol is a leading cause of 
cirrhosis and that alcohol is recognized as a human 
carcinogen. 
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Another study on self-reported health of adults and 
children living in the same family in a national repre-
sentative US sample from 2008 to 2010 has highlighted 
the importance of residual confounding as a major 
source of misleading results. The study found that 
family members including children who co-habited 
with light to moderate drinkers but who were not 
necessarily themselves drinkers had better health than 
abstainers.56 This ‘shared’ protection is unlikely to be 
due to physiologic effects from alcohol, particularly in 
relation to those under 18 years (most of whom would 
have been non-drinkers). Rather, the finding is more 
likely to be explained by shared socioeconomic and 
lifestyle characteristics. 
Furthermore, several studies have found that offspring 
of mothers who consumed small amounts of ethanol 
during pregnancy have better developmental outcomes 
compared with offspring of mothers who abstained 
from drinking during pregnancy. This is likely a result 
of residual confounding remaining after attempts to 
control for the markedly privileged socio-economic 
status of low-volume drinking mothers, particularly 
since ethanol is the world’s leading fetal neurotoxin.57
That people in southern France seem to have lower 
rates of heart disease in spite of eating food rich in fat 
and drinking alcohol, mainly wine, has been called 
‘the French paradox’ - a well-publicized phenomenon. 
However, in a recent study randomised with respect 
to the Mediterranean diet but not in relation to 
alcohol consumption found that those consuming the 
Mediterranean diet had a lower risk of cardiovascular 
mortality. This shows that the apparent cardiovascular 
benefit asserted by the ‘French paradox’ can be ex- 
plained by diet, irrespective of alcohol consumption.58 
Another explanation of a large part of this seeming 
paradox may be the coding practices of French doctors, 
who have been shown to overuse non-specific codes for 
cardiovascular disease referred to as ‘garbage codes’, 
which has the effect of artificially lowering the reported 
prevalence of ischaemic heart disease per se.59
Misclassification of drinkers and abstainers
In the classic studies, the relationship between drin-
king level and risk of disease or death is described 
as a J shaped curve, where “moderate” drinkers are 
observed to have a lower risk than people classified as 
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Figure 1. A hypothetical example of a J-curve. The risk for abstainers is set at 1, and falls for low-dose consu-
mers, rising in conjunction with increased consumption.
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“abstainers” but those drinking at heavier levels have 
higher risk than abstainers. 
Numerous problems can arise in these studies, 
however, in relation to how accurately different studies 
classify who is an abstainer and who is a moderate 
drinker. Failure to make this classification accurately 
can lead to biased comparisons between these two 
groups. Mostly, such biases cause the people identified 
as moderate drinkers to appear healthy in comparison 
with those classified as abstainers. The best-known 
example of this is sometimes referred to as the “sick 
quitter effect” whereby former drinkers are mixed 
in with lifetime abstainers. Because people who give 
up alcohol have significantly worse health profiles, 
this procedure contaminates the abstainer reference 
group and makes the moderate drinkers “look good” by 
comparison. 
There are several other examples of drinker misclas-
sification errors which can bias this literature. In 
many developed countries it has been observed that 
as people age and become increasingly frail they also 
tend to either completely abstain from drinking or 
cut right down and become occasional drinkers. The 
common practice of combining these near abstainers 
into the abstainer reference group could therefore also 
create bias by making this reference group less healthy 
and hence moderate drinkers appear more healthy by 
comparison. A well-known review of this literature by 
Fillmore et al (2006) 60 attempted to identify all the 
studies which contained either former or occasional 
drink bias i.e., the abstainer reference group included 
former and/or occasional drinkers. They reported that 
among the relatively few (seven) studies which did 
not contain such bias there was no longer evidence of 
reduced mortality risk among moderate drinkers.
It is important to stress that misclassification errors 
are the rule rather than the exception among studies 
of the relationship between alcohol consumption and 
health. Specifically in relation to the literature on 
cardio-protection and moderate drinking, Stockwell 
and colleagues (2012) 61 examined the 84 studies used 
by Ronksley et al (2011) 62 in their influential meta-ana-
lysis with a view to identifying how many contained 
serious methodological problems including misclas-
sification evidence. As illustrated in Figure 2 below, 
after eliminating studies that were duplicates, that did 
not control for basic lifestyle confounding factors such 
as smoking and that did not adequately measure both 
quantity and frequency of alcohol consumption, only 
49 studies remained. Among these 49, 32 contained 
former drinker bias and a further seven contained 
occasional drinker bias i.e. former and/or occa- 
sional drinkers were included in the reference group of 
“abstainers”. A further eight studies contained “reverse 
occasional drinker bias” whereby occasional drinkers 
were grouped with moderate drinkers which is also 
capable of biasing comparisons with abstainers. The 
two remaining relatively error-free studies produced 
Summary of
analysis of 84
Ronksley et 
al, 2011 studies
84 articles met criteria
67 unique studies
63 studies retained
59 studies retained
49 studies retained
17 studies retained
2 studies retained
8 had occasional drinkers mixed 
with moderate drinkers
17 duplicates excluded
4 had no control for 
smoking or health
4 assessed drinking for 
less than 30 days
10 did not assess quantity 
and frequency of use
32 had former drinker bias
7 had occasional drinker bias
Figure 2. From Stockwell et.al. (2012), How good is the science. BMJ 2012, 344:e2276, reference 61.
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inconsistent findings in relation to the presence of 
cardio protection. 
Another perspective on the “sick quitter effect” or 
former drinker bias, is that it is insuf-
ficient to separate out these former 
drinkers into their own group and 
report mortality outcomes for them 
separately from people who continue 
to drink. Over the course of these 
long-term observational studies, 
arguably this just result in weeding 
out sick people with poor outcomes 
from different groups of drinkers 
including those classified as “mode-
rate”. Liang and Chikritzhs (2013) 63 
pursued this idea and investigated 
what happens to the J shaped curve 
when former drinkers are classi-
fied into different groups of current 
drinkers. Since past drinking status 
of former drinkers is rarely known 
or recorded in cohort studies, Liang and Chikritzhs 
obtained an estimate of this by using multiple imputa-
tions, a common strategy used for dealing with missing 
values. They demonstrated that when former drin-
kers were placed back into drinker groups, evidence 
of health protection at light and moderate levels was 
substantially diminished.
Liang and Chikritzhs (2013) 64 argue that this real-
location of former drinkers is necessary and is akin to 
the problem of dealing with missing cases in rando-
mised clinical trials. If either the treated or untreated 
individuals in such studies are more likely missing at 
follow-up this will create bias. An “intention-to-treat” 
approach is recommended to deal with this problem 
so that missing cases are included in the final analysis, 
both of the treated and untreated groups. It is sugges- 
ted that to be analogous with a clinical trial approach 
and to avoid bias, data on former drinkers should be 
replaced back into a drinking category which best 
describes their past level and pattern of alcohol expo-
sure. This methodological problem has also been recog-
nised in tobacco research where it has been emphas-
ized that ex-smokers and current smokers should be 
combined in analyses rather than being treated as two 
distinct groups.65
Epidemiological studies rely heavily on accurate 
participant recall, that is, an individual’s ability to 
faithfully report the quantity and frequency of their 
own drinking. Unfortunately, recall bias, whereby 
people (invariably) underestimate their drinking, is 
well documented in relation to self-reported alcohol 
consumption.66 This is a particular problem for studies 
of alcohol and chronic disease as it undermines the 
ability of researchers to correctly classify drinkers 
and non-drinkers. A study based on the 1958 British 
Birth Cohort provides a striking example of the 
extent of recall bias in relation to alcohol exposure. 
Caldwell et al. reviewed respondent’s own reports of 
their current alcohol use (e.g. non-drinker, occasional 
drinker, drinks on most days) at ages 16, 23, 33, 42 
and 45 years. Remarkably, some 60% of 45 year old 
respondents who self-identified as ‘never’ drinkers had 
actually reported drinking alcohol 
at any one of the previous follow-up 
surveys -- almost a quarter had 
previously reported drinking at least 
once a week. Moreover, almost 60% 
of 45 year olds who self-reported as 
lifetime ‘occasional only’ drinkers had 
previously reported drinking at least 
once a week.67 
Although misclassification is an 
important type of selection bias, there 
are other types of selection bias that 
confront studies of alcohol consump-
tion. After one begins drinking one 
might become a moderate drinker, 
quit drinking, become a heavy 
drinker, or die prior to the study’s 
inception. In observational studies, these last three 
possibilities are not taken into account. Quitters have 
been discussed previously, but even if former drinkers 
are correctly classified as such, removing them from 
the analysis biases results in favour of moderate drin-
kers because former drinkers are generally unhealthy, 
regardless of whether they stopped due to the effects of 
alcohol or for other reasons. However, from an inten-
tion-to-treat perspective, their poor outcomes should 
rightly accrue to drinkers. In addition, heavy drinkers 
are ignored since they do not meet inclusion criteria as 
moderate drinkers. Not including those who already 
died also biases results in favour of drinking, assuming 
that deaths at young ages among drinkers are more 
likely to be from alcohol than they are to be from not 
drinking among non-drinkers. This is likely the case, 
since alcohol consumption is a leading cause of death 
among young and middle aged persons, and because 
protective effects of alcohol are not observed in young 
age groups.
Publication bias
Another concern with this literature is that bias may 
be present in terms of which types of studies are more 
likely to get published. It is known to be harder to 
publish studies with no significant results and studies 
finding that alcohol in moderation is good for you may 
be more likely to be published. It has also been sugges- 
ted that wealthy commercial groups with an interest 
in the sale of alcoholic beverages are more likely to 
fund researchers with a track record of using methods 
which detect health benefits from drinking. Evidence to 
support this concern was reported in one of the major 
early reviews of this literature by Corrao and collea-
gues.68 They concluded that among smaller studies, 
estimates of mortality risk among moderate drinkers 
were skewed significantly downwards away from mean 
values.
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3.2. Contradictory lines of evidence 
from epidemiological studies
Increases in aggregate per capita alcohol 
consumption are not associated with reduced CVD
Aggregate-level studies can eliminate bias in individu-
al-level studies, and it is important to weigh together 
evidence from various sources of data: clinical, 
observational as well as aggregate data, rather than to 
rely on one kind of data only. For example, if there is a 
substantial cardioprotective effect of low-dose drin-
king, mortality rates would be expected to respond to 
changes in aggregate consumption. If there is no aggre-
gate-level effect on cardiovascular disease of changes 
in drinking, the explanation could very well be that the 
cardioprotective effect is the result of confounding in 
individual-level studies or that it is too small to be of 
much interest from the point of view of public health.69
It is well established from international studies that 
changes in per capita alcohol consumption are signi-
ficantly and positively correlated with corresponding 
changes in rates of alcohol-related diseases. One study 
of 14 European countries spanning over 45 years 
of data found that this held for a number of specific 
outcomes such as liver cirrhosis and injury rates as well 
as for total alcohol-related mortality.70, 71, 72, 73 However, 
no relationship was found between per capita alcohol 
consumption and rates of cardiovascular mortality.74 
A similar study on Canadian data from 1950 to 1998 
reported an increase of IHD mortality of one per cent 
for a 1-litre increase in per capita consumption, but 
the estimates did not reach statistical significance. 
The study concludes that an increase in overall alcohol 
consumption is more likely to cause an increase in 
IHD mortality than to lower the number of IHD 
deaths.75 A study on data from US states from 1950 to 
2002 found a similar effect on total consumption of 
alcohol, i.e. an increase of one per cent IHD mortality 
per litre of alcohol.76 A study of Norwegian time series 
data from 1955 to 1977 reported a protective effect of 
alcohol bordering on statistical significance between 
per capita alcohol consumption and ischaemic heart 
disease mortality only in the age group 60-74 years.77 
This effect was only apparent the same year as per 
capita consumption changed. A study from Hong Kong 
in connection with a decrease of excise taxes on beer 
and wine by fifty per cent in March 2007, reported that 
ischaemic heart disease mortality increased by 18% 
for elderly men and 15% for elderly women. Alcohol 
duty on beer and wine was eliminated one year later, in 
March 2008, but this was not found to have impacted 
the CVD death rates.78
Several aggregate population level studies have 
reported an increase in total mortality related to 
an increase in alcohol consumption. In a study of 
25 European countries between 1982 and 1990, an 
increase in consumption of one litre of pure alcohol 
increased total mortality by 1.3 per cent.79 A study of 
European countries demonstrated that mortality signi-
ficantly increased with increasing consumption in eight 
out of 14 countries. The effect on mortality tended to be 
stronger in low-consumption countries (3% per litre) 
than in medium- and high-consumption countries (1%). 
In no country were increases in consumption signifi-
cantly associated with decreased mortality.80 A similar 
effect was found for Canada where for every one litre 
increase in per capita consumption there was a 1.7 per 
cent increase in total mortality.81
While measures of per capita alcohol consumption 
of the population do not discriminate between light, 
moderate or heavy drinking, some authors have sugge-
sted that there may be cardiac benefits for heavy as well 
as moderate drinking.82, 83 If this was the case, arguably 
increases in per capita alcohol consumption should 
result in reductions in cardiovascular disease but this 
has been shown not to occur. These findings weaken 
the argument that alcohol exposure is causally related 
to reduced risk of mortality.
No CVD benefit from low-dose consumption among 
non-white and non-Western Cultures
Several studies report no reduced risk for heart disease 
or mortality for non-white or non-western cultures. 
In a study by Flavio Fuchs the risk for coronary heart 
disease increased linearly for black American men but 
decreased for white male consumers of low doses.84 
A study on different ethnic American groups found 
a reduced risk for mortality only in whites but not in 
blacks or Hispanic.85 Similarly in studies on Chinese or 
Indian alcohol consumption, cardiovascular disease is 
reported to increase already at low-dose consumption 
of 1-6 drinks per week.86, 87, 88 This raises the question 
whether not alcohol consumption, and especially 
moderate consumption, is a sign of healthy living, 
rather than the cause of reduced risk, a connection 
that is present in some cultures but not in others. This 
is in agreement with the positive effects of fish oil 
consumption and other dietary elements on mortality 
and cardiovascular disease seen in large observational 
studies, an effect not easily repeated in randomised 
controlled trials.89 
Importance of assessing cohorts over the life 
course, ideally soon after drinking initiation
Another line of concern has emerged from a recent and 
thorough investigation of a large cohort (n=400,000+) 
from the European Prospective Investigation into 
Cancer (EPIC) reported by Bergmann et al.90 This study 
recognized the fact that over the life course individuals 
have competing risks of death from different causes. 
Earlier in life there is a greater risk of death from 
injuries while death from cardiovascular disease tends 
to occur much later in life. By only examining risk of 
death from one particular outcome at a time and igno-
ring these competing risks, biased results may emerge. 
If drinkers are more likely to die from alcohol-related 
causes earlier in life it may give the appearance that 
risk of death from a different cause such as coronary 
heart disease later in life is produced for surviving 
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drinkers. This problem is exacerbated based on the 
length of time that elapses between the age of drinking 
initiation and the time in which a study group or cohort 
is identified, or by having study populations that are 
relatively older in age. After conducting their compe-
ting risk analysis the authors of the study concluded: 
“The apparent health benefit of low to moderate alco-
hol-use found in observational studies could 
therefore in large part be due to various 
selection biases and competing risks, which 
are related to both lifetime alcohol-use and 
risk of disease, usually occurring later in 
life.”
In a US study the relationship of life-
course drinking patterns to 
diabetes, heart problems, and 
hypertension among those 
40 and older in the 2005 was 
assessed. Normally, studies 
only take into account current 
drinking as reported by those 
who participate. The study did 
not find evidence of a protec-
tive effect of life-time moderate 
drinking on heart problems or 
hypertension, nor did it find evidence of increased risk 
for heart problems among lifetime heavy drinkers. The 
results did confirm previous findings of a protective 
effect of lifetime moderate drinking on diabetes risk.91
Contradicting examples exist also for diabetes. A study 
on a national representative sample of adolescents 
in the USA reported that adolescents with a frequent 
heavy alcohol use (consuming an average of 5+ drinks 
on 3 or more days/week) was 12 times more likely to 
develop diabetes than abstainers.92 In a review of seven 
cohort studies on Japanese, alcohol consumption, 
even at low doses were linked to an increased risk of 
diabetes. The effect was larger for men with a rela-
tive low BMI (BMI <= 22). For higher BMI the results 
varied. Some of the studies reported a lower risk for 
diabetes and some a higher risk.93 
3.3. Some biological mechanisms 
supporting the plausibility of  
cardiovascular protection are now 
in question, or are inconsistent with 
epidemiologic studies 
Biological mechanisms that can be the cause of a 
correlation found in observational studies strengthen 
the plausibility that an observed correlation is causal, 
e.g. the correlation between low-dose alcohol consump-
tion and coronary heart disease. Such mechanisms 
have been found and a review and meta-analysis of 44 
RCT laboratory studies found that moderate alcohol 
consumption had favourable effects on levels of the 
good cholesterol high density lipoprotein (HDL) choles-
terol, apolipoprotein A1, adiponectin, and fibrinogen. 
The study concluded that the results strengthened 
the case for a causal link between alcohol intake and 
reduced risk of coronary heart disease. The analysis 
found that alcohol consumption did not affect a number 
of other factors also associated with risk of coronary 
heart disease, as total cholesterol, low density lipopro-
tein (LDL) cholesterol, triglycerides, Lp(a) lipoprotein, 
C reactive protein, interleukin 6, tumour necrosis 
factor α, plasminogen activator inhibitor 1 and 
tissue plasminogen activator antigens.94 
HDL cholesterol
Experimental studies show that alcohol consump-
tion results in increases in HDL, and this has been 
the most compelling source of biologic plausibi-
lity for how alcohol might reduce 
CVD. However, the cardioprotective 
effect of HDL has recently come 
into question. First, a meta-ana-
lysis of studies on the use of statins 
and other lipid-lowering drugs, has 
shown that these medicines have no 
independent effect on CVD morta-
lity after controlling for their effects 
on the “bad cholesterol” (i.e., LDL 
cholesterol).95 Second, pharmaceu-
tical drugs that raise HDL levels have not resulted in 
decreases in CVD mortality.96 And third, Mendelian 
randomisation, in this case focusing on a genetic effect 
that raises HDL in the blood, study results have also 
shown no effect of higher HDL levels for reducing the 
risk for myocardial infarction.97 
Coronary calcification, carotid intima-media 
thickness
Serum biomarkers such as HDL are thought to work 
through improvements in vascular health. However, 
histologic markers of vascular health are a more 
proximate indication of vascular health than serum 
biomarkers, and alcohol consumption is associated 
with worse vascular health by these measures. For 
example, coronary calcification was measured over 
15 years in a sample of 3,037 U.S. participants aged 
33–45 years. It was found that coronary calcification 
was associated with increased rates of atherosclerosis 
at all levels of consumption. Among those consuming 
less than 7 drinks per week the risk was increased by 
10 % compared with abstainers, was 50% higher among 
those drinking on average 7 to 14 drinks per week and 
100% higher for those drinking more than 14 drinks 
per week. Among binge drinkers the risk was also 
doubled. The lowest proportion of participants with 
coronary calcification was found among lifetime abstai-
ners.98 Similarly, a study on Finnish data on carotid 
intima–media thickness (IMT), a marker of subclinical 
atherosclerosis, in young, healthy adults found a direct 
positive relationship between alcohol consumption 
and carotid intima–media thickness, with a significant 
increase starting from consumption of less than two 
drinks per day compared to non-drinkers.99 
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Brain atrophy, cognition
A number of epidemiological studies find that low-dose 
alcohol consumption is associated with better cogni-
tion. However, a study on middle-aged US men found 
that each additional drink per week was associated 
with increased brain atrophy as measured by MRI 
imaging.100 In addition, two recent Mendelian rando-
misation studies found no association between alcohol 
use and improved cognitive ability.101, 102 Collectively, 
these findings further strengthen the notion that the 
observed apparently beneficial effects on cardiovas-
cular health among low and moderate drinkers may 
actually reflect good cognitive health, rather than cause 
good cognitive health.
Blood pressure, hypertension
Although a number of epidemiologic studies find a 
linear relationship between alcohol consumption 
and blood pressure and hypertension,103 others find a 
J-shaped curve in which low-dose alcohol consump-
tion is associated with lower blood pressure.104, 105, 
106 However, in a meta-analysis of Mendelian rando-
misation studies of a gene related to reduced alcohol 
consumption, alcohol consumption increased blood 
pressure and the risk of hypertension among men, even 
at moderate levels of consumption. The researchers 
were also able to estimate that for men, the lifetime 
effect of drinking 1 g of alcohol a day (1/12 standard 
drink in Sweden) increased systolic blood pressure by 
0.24 mmHg. No association was found in females, for 
whom drinking levels were low in the studies.107 
3.4. New genetic evidence: Mendelian 
randomisation study suggests CVD 
harm, not benefit, from alcohol 
consumption, even at low doses
In the absence of clinical RCTs, genetic (Mendelian) 
randomisation studies are perhaps the strongest 
available study design to assess the effects of alcohol 
consumption, particularly for chronic disease-re-
lated outcomes. The distribution of genetic variants 
is usually random in a population, and can therefore 
minimize the leading sources of bias encountered in 
observational studies. Furthermore, because genes are 
present from birth, they can better capture the effects 
of lifetime exposures to a particular factor. 
Although this type of study has been used to assess the 
relationship of alcohol consumption with health-related 
conditions and risk factors (e.g., blood pressure, HDL, 
cognition), it is only very recently (July, 2014) that 
this study design has been applied to cardiovascular 
mortality.108 This is important since CVD is the driver 
behind the possible mortality benefit among those who 
consume modest amounts of alcohol.
REASONS FOR SCEPTICISM ABOUT EFFECTS 
OF LOW-DOSE ALCOHOL CONSUMPTION
• Benefits have not been confirmed in controlled studies
• Other observed health benefits have not been confirmed by RCTs
• Biological mechanisms for health benefits recently disconfirmed
• Evidence for adverse physiological effects of low-dose alcohol
• “Moderate” drinkers have generally healthier lifestyles than abstainers
• Many studies systematically exclude unhealthy drinkers
• Most studies misclassify unhealthy ex-drinkers as abstainers
• Unlikely health benefits observed e.g. liver cirrhosis, cancer, deafness
• Benefits usually observed only in Caucasian populations
• Genetic disposition to drink less provides reduced coronary risk
• Studies showing benefits are more likely to be published
• Reduced population drinking is not associated with increased CVD
ALCOHOL RESEARCH REPORT 2014
19
Individuals with genetic variants of alcohol meta-
bolism genes that are associated with less alcohol 
consumption were compared to individuals without 
this variant. If the protective effect of alcohol consump-
tion on CVD mortality were real, one would expect 
the group carrying the genetic variant to have a higher 
risk of cardiovascular mortality because of their lower 
alcohol consumption. However, this study of more than 
260 000 individuals showed that individuals with a 
genetic predisposition to consume less alcohol had 
lower, not higher, mortality rates from coronary heart 
disease. This effect was observed among those within 
low and moderate drinking categories. Furthermore, 
the fact that the genetic variant was not significantly 
associated with CVD mortality among non-drinkers is 
evidence that this genetic variant does not affect CVD 
except through its effects on alcohol consumption. In 
addition, there was no association of the gene with type 
2 diabetes or coagulation markers. 
SECTION 4. SUMMARY, 
IMPLICATIONS FOR PUBLIC 
HEALTH
This report is primarily a summary and critique of the 
methodology and evidence in scientific research on the 
effects of low-dose alcohol consumption. To date, all 
studies of the relationship between alcohol consump-
tion and morbidity and mortality outcomes have been 
observational by nature (i.e. mainly non-randomised 
cohort and case-control studies). While there are 
many epidemiological studies of this nature, they all 
suffer from the same fundamental weaknesses that are 
inherent in observational research illustrating that a 
substantial body of observational studies can be consis-
tently wrong. 
In general, the chief threats to validity for observa-
tional studies are confounding and selection bias, 
and recent evidence demonstrates that observational 
studies about effects of low-dose alcohol from deve-
loped countries are plagued by both. These methodo-
logical problems are clearly apparent in a number of 
studies where protective effects from low-dose alcohol 
are found despite the absence of any biologically plau-
sible mechanism, including deafness, hip fracture, the 
common cold, and alcoholic liver cirrhosis. 
Fundamentally, observed associations can be caused by 
a variety of other lifestyle factors as well as socio- 
economic and psychosocial factors which may be 
independently associated with alcohol consumption in 
the population being studied. These background factors 
can to some extent be controlled through statistical 
methods, but the extent to which this has been done 
varies considerably. Furthermore, there are many 
factors that are only partially understood, and, most 
likely, many factors that are unknown. 
The reported beneficial effects of alcohol are largely the 
result of comparisons with abstainers. It has become 
increasingly clear however that many abstainers are 
at higher risk for ill health in ways unrelated to their 
non-consumption of alcohol. 
Another major source of methodological uncertainty in 
observational research is the misclassification of rese-
arch subjects. Numerous problems can arise in these 
studies in relation to how accurately different studies 
classify who is an abstainer and who is a moderate 
drinker. Failure to make this classification accurately 
can lead to biased comparisons between these two 
groups. Mostly, such biases cause the people identified 
as moderate drinkers to appear healthy in comparison 
with those classified as abstainers. The best-known 
example of this is sometimes referred to as the “sick 
quitter effect” whereby former drinkers are mixed in 
with lifetime abstainers. Because people who give up 
alcohol tend to have significantly worse health profiles, 
this procedure contaminates the abstainer reference 
group and makes the moderate drinkers “look good” by 
comparison. Furthermore, it is insufficient to separate 
out former drinkers into their own group and report 
mortality outcomes for them separately from people 
who continue to drink. Over the course of long-term 
observational studies, this arguably results in weeding 
out sick people with poor outcomes from different 
groups of drinkers including those classified as “mode-
rate”. To avoid spurious conclusions, reallocation of 
former drinkers may be necessary and is akin to the 
problem of dealing with missing cases in randomised 
clinical trials.
Correlations between alcohol and health outcomes 
found in observational studies also require plausible 
biological mechanisms to be considered causal. Such 
mechanisms have been identified and include favou-
rable effects of moderate alcohol consumption on some 
blood biomarkers such as high density lipoprotein 
(HDL) cholesterol. A number of RCTs, summarized 
in a review and meta-analysis have supported this 
effect. However, the cardioprotective effect of HDL 
has recently come into question so that the alcohol-in-
duced increase of HDL should also be questioned. 
Recent research on atherosclerosis demonstrates that 
alcohol consumption is only positively associated with 
coronary calcification and increased carotid artery 
thickness. The lowest risk of coronary calcification was 
found among lifetime abstainers. 
In the medical literature, many observed associations 
are confirmed in subsequent randomised controlled 
trials. However, this is not always the case, and some 
notable exceptions have been recorded in which 
multiple observational studies were subsequently 
refuted by RCTs. Notable examples described in this 
report include beta carotene intake for the reductions 
in CVD and cancer, and hormone replacement therapy 
for the reduction of CVD, among other examples. 
However, both beta-carotene and hormone replacement 
therapy, were found to be ineffective when subjected to 
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performing randomised controlled studies, where 
both known and unknown background variables can 
be controlled through randomisation, but so far no 
RCTs have been performed in this area. This scientific 
standard is warranted particularly for an agent that is a 
leading cause of death, disability and social problems.
The protective effect of moderate drinking is not 
commonly found in different ethnic groups, eg black 
American men, Chinese and Indian populations. 
This adds to doubts about the cardioprotective role 
of alcohol, as opposed to other lifestyle factors and 
cultural differences. 
Aggregate level research from many countries invol-
ving whole populations finds that changes in per capita 
alcohol consumption are significantly and positively 
correlated with corresponding changes in rates of 
alcohol-related diseases. However, no relationships 
have been found between per capita alcohol consump-
tion and rates of cardiovascular mortality. This is yet 
another indication that the cardioprotective effect may 
be confounded in individual-level studies.
In the absence of randomised controlled trials on 
alcohol and mortality, Mendelian randomisation 
studies which utilize genetic variants that affect alcohol 
consumption in individuals have emerged as a good 
alternative to randomised clinical trials. A recent 
meta-analysis found that those with a genetic predis-
position to consume less alcohol had lower, not higher, 
odds of dying from coronary heart disease, including 
among those with moderate alcohol consumption. 
This is a powerful piece of evidence suggesting that 
concerns with observational epidemiologic studies of 
the health effects of low-dose alcohol on cardiovascular 
health are justified.
4.1 Implications of weak evidence for 
health benefits: Why it matters 
Our conclusion is that the evidence of protective effects 
for low-dose alcohol consumption is surprisingly weak, 
and does not warrant the far reaching conclusions that 
have been drawn from it. This report should be consi-
dered in the context of the fact that alcohol consump-
tion in general is a major negative health determinant 
in terms of mortality, morbidity and social problems. 
Furthermore, alcohol results in far more adverse 
health impacts than it prevents, even assuming some 
cardiovascular benefit for low-dose consumption. With 
new research being reported over the last decades, 
estimates of the total disease burden caused by alcohol 
has increased considerably. New disease categories 
have been added, where the role of alcohol had not been 
recognized earlier. This particularly applies to cancer, 
where alcohol now is recognized as a major carcino-
genic agent. 
For clinicians: drinking guidelines, whether drinking 
should be recommended 
While it is possible that low-dose alcohol consumption 
may be beneficial for some health outcomes including 
cardiovascular disease, the current evidence in support 
of this is weak. However, the appeal of purported 
health benefits, and of alcohol in particular, clearly 
has resulted in a lower than usual scientific standard 
when evaluating evidence for clinical intervention. 
No randomised controlled studies have been under-
taken in contrast to what is required for most medical 
procedures or pharmaceutical products. Furthermore, 
the many side effects of alcohol, if viewed as a pharma-
ceutical, would prohibit its use, even in very moderate 
doses. 
Given the lack of evidence from randomised trials and 
considering the many negative consequences of alcohol 
consumption, public health recommendations should 
remain focused on: 1) reducing excessive drinking 
among those who already drink, and 2) dis- 
couraging initiation of alcohol consumption or more 
frequent drinking on the basis of health and safety 
considerations. 
Implications for policy
The purported beneficial effects of low-dose alcohol 
consumption have been used as an argument against 
the implementation of effective population-level poli-
cies. Given the strong possibility that there are actually 
no cardio-protective effects and given the negative 
effects of alcohol, there are no reasons to oppose effec-
tive policies to reduce alcohol-related harm, e.g. raising 
alcohol prices and restricting the physical availability 
of alcohol. 
However, even if there were cardio-protective effects, 
there are still compelling reason to adopt public popu-
 Strong alcohol control 
policies targeting price 
and availability should 
not be undermined by 
claims of beneficial ef-
fects of low-dose alcohol 
consumption.
The initiation of alcohol 
consumption should not 
be recommended for 
reasons of health.
ALCOHOL RESEARCH REPORT 2014
21
lation-based polices to reduce alcohol consumption. 
First, alcohol consumption results in far more adverse 
health impacts than it is thought to prevent. Second, 
the evidence of negative effects of excessive alcohol 
consumption is more robust than for effects of low-dose 
consumption for the following reasons: 1) alco- 
hol is a predominant risk factor or has 100% attribu-
tion in many conditions; 2) These associations have 
large effect sizes; and 3) many conditions have short 
latency periods between the exposure to alcohol and 
the adverse outcomes. Third, current meta-analyses 
of all-cause mortality suggest that the lowest risk for 
death is associated with very low levels of consumption 
(approximately half a drink a day for women and less 
than one per day for men). Therefore, population-wide 
reductions in consumption through the implementing 
effective alcohol policies would not only reduce the 
death and disability from excessive drinking, but could 
increase the number of persons to whom any benefits of 
moderate consumption might accrue.
The disease burden of alcohol is enormous. Over the 
centuries nations have struggled with the challenge to 
control and reduce the costs from alcohol to individuals 
and society. There are clearly opposing forces in this 
struggle. On the one hand are commercial forces that 
gain profit from increased consumption of alcohol and 
on the other hand are health and safety interests that 
seek to reduce the harm from alcohol through reduced 
drinking. 
A message that moderate drinking is good for health 
has been used to undermine efforts to achieve effective 
alcohol policies on the national level. This message 
also sometimes confuses medical practitioners as to 
appropriate advice regarding alcohol consumption. The 
grounds for challenging the protective effects of mode-
rate drinking have increased. This report attempts 
to summarise the scientific evidence concerning this 
issue. It concludes that the evidence for the beneficial 
health effects of moderate drinking in many respects 
is quite weak and should not compromise society’s 
response to the problems caused by alcohol.
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BEER IS GOOD FOR THE 
HEART! WINE CAN CAUSE 
CANCER! –  
MEDIA ATTITUDES TOWARDS 
ALCOHOL RESEARCH
By Sara Nilsson
“Alcohol protects your heart.”
“Alcohol linked to increased cancer risk.”
“A little wine boosts your memory.”
As readers, we encounter a veritable flood of contra-
dictory news on the ways in which alcohol affects our 
health.
In the following article, news 
chiefs and reporters from 
Sweden’s biggest newspapers 
discuss the way they regard the 
latest research on alcohol and 
their responsibility for the risk/
benefit pictures painted by their 
news.
Readers encounter articles based 
on the latest research findings 
about the effects of alcohol on 
health in both the morning 
broadsheets and evening 
tabloids. A small dose is good for 
your sense of smell, drinking in the sun increases the 
risk of skin cancer, and alcohol is an effective means of 
preventing aneurysms, are just a few examples of the 
kind of articles readers see.
Sweden’s biggest news website, aftonbladet.se, is no 
exception, and the latest findings on alcohol have a 
natural place here amongst the celebrity gossip, foreign 
news, and sports news.
“Alcohol plays a major part in our society and is 
consumed by so many people that writing about it 
is often of considerable interest to us”, says Martin 
Schori, Assistant News Director at aftonbladet.se. 
According to Schori, the world of journalism and the 
tabloid evening papers has a history of glorifying 
alcohol consumption, but he believes that attitudes 
have changed at Aftonbladet.
“There’s an increased awareness, nowadays, of the fact 
that we shouldn’t romanticise alcohol when we write. 
But yes, things do slip through the net from time to 
time”, says Schori.
Many people believe that 
the tabloid press will write 
anything at all in their hunt 
for clicks or newsstand sales. 
But Martin Schori points out 
that traditional newsworthi-
ness standards still apply – 
what they write must be true, 
relevant and interesting – and 
he believes that they do pay 
attention to the picture they 
are painting of the benefits or 
risks of alcohol consumption.
“There’s this prejudice that 
we never think twice before 
we publish, but that’s just not 
the case. We’re no longer a complementary medium 
that people read for entertainment purposes: we’re 
the only news source for a lot of people. Which is why 
we’ve had to position ourselves and to rethink – inclu-
ding when it comes to the way in which we write about 
alcohol”, says Schori.
According to Martin Schori, an expert is often asked to 
comment on the study, in order to assess its veracity. 
Alternatively, they use sources that are deemed to be 
credible, such as certain foreign newspapers, universi-
ties or publications.
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Anna Bäsén, medical reporter for the Expressen news-
paper, agrees that new research into alcohol is of inte-
rest to her newspaper because alcohol affects so many 
people. She also believes that that the newspaper has a 
responsibility for the picture they paint of the benefits 
or risks of alcohol consumption.
“Obviously, we have to try and provide balanced 
reporting. And there are undoubtedly times when we 
succeed very well in this respect, and times when we 
don’t.”
“I try to communicate the risks when I write. When the 
piece is about cardiovascular health and alcohol, for 
example, I try to make it clear that the group of people 
who might benefit is a small one – namely the elderly 
– and that for a lot of people, they really shouldn’t be 
increasing the amount they drink. That, in fact, the 
opposite is true”, says Bäsén.
Research-based news on the health effects of alcohol 
can, as noted above, be found in both the broadsheet 
morning press and the tabloid evening press and Anna 
Bäsén sees no great difference between them when it 
comes to the way in which the articles are put together.
“We report research news in pretty much the same 
way as the big morning papers. When people say there 
are huge differences, they’re probably mainly thinking 
about our placards or lifestyle magazines”, says Bäsén.
According to Bäsén, it is, in fact, the broadsheets who 
have moved closer to the tabloids, partly by picking up 
on the massive interest in health issues, and partly due 
to the fact that, nowadays, they write in a simpler and 
more populist style.
“They’ve also moved our way when it comes to 
making things more personal. They don’t just include 
comments from a professor or expert in the article, 
they include someone directly affected. Someone who 
says, ‘I lowered my blood pressure by drinking less 
alcohol’”, notes Bäsén.
Anna Bäsén sees no problem with the fact that readers 
can one day be confronted by news saying that alcohol 
is good for your health, and another, by news that it 
is bad, and says it is a feature common to all forms of 
health reporting. As she sees it, there are both advan-
tages and disadvantages to alcohol consumption, and 
the media must be able to present it that way.
“Researchers do, after all, disagree sometimes and 
we have to be able to show that. Our job is to report 
on the research findings and we have to be able to do 
that before the authorities or other organisations have 
reached their own conclusions on a given issue. Acting 
as a megaphone for Sweden’s Public Health Agency 
or the National Board of Health and Welfare, or for 
anyone else, come to that, is not our job”, says Bäsén.
She adds that the fact that contradictory research 
exists, or that a new study might show the complete 
opposite of what was previously believed, should also 
be borne in mind.
“Different studies can show different things”, says Lena 
Karvik, Acting Head of the Newsroom at the broads-
heet morning newspaper, Svenska Dagbladet. She also 
sees nothing wrong with the fact that the news with 
which readers are presented alternates between saying 
that alcohol is good and bad for your health.
“We’re not promoting a particular scientific policy or 
line. We take a view on each thing we publish on a case 
to case basis, so that can happen. The important thing 
is that we demand certain standards of the research-re-
lated news we write about. We attempt, in every article 
we write, to give the readers everything they need to 
understand the news and we will always say if other 
studies point in the opposite direction. That’s what we 
aim to do, anyway”, says Karvik.
A fundamental requirement for publication in Svenska 
Dagbladet is that the studies about which they write 
must have been published in a scientific publication 
or come from an accepted source, such as a respected 
university or research group. The newspaper also looks 
at what type of study it is in order to determine how 
reliable it is, the method used, and the study’s financing 
source.
Similar criteria apply at the Dagens Nyheter morning 
broadsheet, according to Maria Gunther, the paper’s 
Science Editor and science reporter. The studies that 
the newspaper covers are generally those published 
in high-status scientific publications and which are 
adjudged to be of a high quality – the conclusions 
drawn must be plausible, and there should not be any 
other possible explanations. She admits that even the 
research published in scientific periodicals falls down 
on quality from time to time, but that the reputation of 
the publication and its status act as a filter for shoddy 
studies.
This approach applies to all research-related news in 
Dagens Nyheter, but studies that show positive health 
effects for alcohol enjoy a special position, according to 
Maria Gunther.
“Alcohol is an enormous public health problem, so we 
always try to include a ‘facts and figures box’ in which 
we state precisely which group the positive effects apply 
to, such as older women, and who it is harmful for, as 
well as stating it clearly in the main text”, says Gunther.
Maria Gunther emphasises the paper’s endeavours to 
give the reader as complete a picture as possible when it 
comes to health effects.
“We live in a complex world, which means the overall 
picture is complex too: a glass of wine might be good 
for your cardiovascular system, but then there are also 
a lot of hazards associated with alcohol. We have to try 
and give readers the full picture, even if that can be 
difficult when space is limited”, says Gunther.
The desire to give their readers the full picture is 
something that is also mentioned by Magnus Persson, 
News Director at the TT Nyhetsbyrån news agency, 
which produces news for a number of Swedish editorial 
departments. 
“If there’s serious research pointing in different direc-
tions, it’s important that we highlight that fact. That’s 
something we bear in mind at all times. Not because we 
feel any sort of social responsibility for public health, 
but because we attempt, as far as possible, to show the 
picture in all its complexity”, says Persson.
This might also involve pointing out any weaknesses 
in the study in question. Or of pointing out those cases 
when research that has shown one particular health 
effect for alcohol has only looked at a minor aspect of 
overall health.
“But then, the way media works is that we take a parti-
cular slant on something in the news and start talking 
about what’s new in the findings. Only then do we get 
to the ‘on the other hand, there is research that points 
in a completely different direction’ bit, and it’s possible 
that not everyone takes that latter part on board”, says 
Magnus Persson.
TT’s quality control procedure mandates that the 
studies must have been published in a scientific 
periodical.
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Frida Dangardt
THE ULTIMATE  
CURIOSITY JOB
By Sara Nilsson
Frida Dangardt, M.D., a researcher at 
the University of Gothenburg, is a new 
member of the group of alcohol resear-
chers who have worked on this year’s 
theme article on low-dose drinking.
Frida Dangardt’s aim, through her research into 
cardiovascular disease risk factors, is to push deci-
sion-makers towards generating better preconditions 
for health.
“There’s a lot of talk about how alcohol is supposedly 
good for your heart and circulatory system. But we 
quickly forget that there is no solid proof of this and 
that the levels in question are so low that virtually 
no one drinks in such small quantities – so all that’s 
left is all the negative health effects”, says Frida 
Dangardt, researcher at the University of Gothenburg 
and a physician at Queen Sylvia Paediatric Hospital in 
Gothenburg.
For Frida Dangardt, this is the first time she has been 
involved in the Alcohol & Society report, which sees a 
group of leading alcohol researchers working together 
to summarise the research position in a specific area 
within the overall field. This year, that area is low-dose 
drinking, and Dangardt says that the decision to accept 
the invitation to take part was an easy one.
“I’m interested in exerting an influence at society level 
and I’m keen to try and help the research that does 
exist become better known and to be presented in a way 
that makes it readily accessible and comprehensible to 
the public and decision makers”, says Dangardt.
Frida Dangardt’s research examines early factors 
in children that may influence the development of 
cardiovascular disease, such as exercise, diet, stress 
and alcohol use. She has shown, amongst other things, 
that overweight children display risk factors for future 
cardiovascular disease at an early stage in their lives, 
and that they can be helped by adding Omega-3 fatty 
acids to their diet.
“Without changing their overall diet or exercise levels – 
simply by giving the children an Omega-3 supplement 
– we were able to improve their vascular function. It’s 
great that there are such simple things that we can do 
to influence the risk factors”, says Frida Dangardt.
These results will, however, have to be confirmed by 
larger studies before general dietary recommendations 
can be issued.
And it is precisely these opportunities to influence 
many people’s health and reduce health inequalities 
that are the key driving forces for Frida Dangardt in 
her work. She responds instantly when asked what her 
research goals are.
“For people to feel better! Either through research that 
persuades people to change their lifestyle, or which 
persuades decision-makers to generate better precondi-
tions for health – not least, children’s health.”
There is a lot that can be done at societal level to influ-
ence the lifestyle factors that she studies, according 
to Frida Dangardt, who mentions physical activity 
in schools as an example. Children of well-educated 
parents often participate in organised leisure activities 
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and get a lot of physical exercise, while children whose 
parents cannot afford these organised activities, for 
example, get virtually no exercise at all.
“In the past, children simply played outdoors anyway, 
but that’s not the case these days. And as a result, 
there’s a huge social difference in health that could be 
equalised with more physical education in schools”, 
says Dangardt.
Frida Dangardt qualified as a doctor in 2005 and now 
works as a paediatric physiologist, but it was by no 
means a given that she would become a doctor at all. 
She started studying civil engineering, but dropped 
out, wanting to work more with people – and preferably 
children – and she thought about becoming a teacher. 
It was not until a study counsellor suggested training 
as a doctor that it struck her that this was one way of 
combining her interest in people with her curiosity 
about how the body works.
Inspired by an enthusiastic – and enthusing – paedi-
atric physiologist, she began researching in this field 
while she was still training to become a doctor and 
defended her doctoral thesis in 2008. She now divides 
her time between clinical work and research and 
tuition at the University.
“I’ve always been curious and research is the ultimate 
curiosity job. The chance to choose which subject you 
want to know about and then to investigate it is just so 
much fun!” says Dangardt.
Frida Dangardt was awarded a public health scho-
larship and spent the last two years in England as a 
visiting researcher at University College London.
“I had the chance to work with some of the world’s 
leading researchers in my field and to study massive 
populations – something we don’t get to do in Sweden”, 
says Dangardt.
She worked, amongst other things, on a study of just 
over 14,000 children being monitored throughout their 
childhoods by drawing samples and completing exten-
sive questionnaires about the children’s dietary habits, 
and Dangardt was able, with the help of data from 
ultrasound investigations and answers to questions 
about alcohol habits from a group of children, to see 
how their circulatory systems are affected by alcohol 
consumption.
“Even at the age of 17, we were able to see that those 
who drink a lot in one go, even if they don’t drink very 
often, had poorer circulatory function, which may 
predict a tendency to develop cardiovascular disease 
when they are older”, says Dangardt.
The results of the study to date have been presented at 
a scientific conference.
Back home in Sweden again now, Frida Dangardt has 
brought with her valuable, ongoing international part-
nerships and a track record of publication in presti-
gious scientific publications. She has also brought back 
insights into what appeals to her about the working 
climate, here in Sweden.
“In England, my colleagues and I just kept on working. 
We didn’t each lunch together, we didn’t take coffee 
breaks together – nothing. The social side of things is 
much nicer here in Sweden and, in my opinion, that 
is ultimately of benefit to the research as well”, says 
Dangardt.
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SOCIOECONOMIC  
DIFFERENCES AND DEATHS  
ATTRIBUTABLE TO ALCOHOL
Low socioeconomic status, e.g. lower education, lower 
occupational status, lower income or unemployment, 
has been shown to be associated with substantial 
higher risk of death. The reasons for this are not clear. 
E.g. lifestyle as physical activity and smoking, or 
psychological factors like stress can explain only part  
of the differences.
In an effort to explain the socioeconomic differences 
in mortality by focussing on alcohol-related deaths, a 
group of researchers have summarized the results from 
15 papers from European countries, together capturing 
about 133 million people, 3 741 334 deaths from all 
causes and 167 652 alcohol-attributable deaths.
The summarized result showed a 70 per cent higher 
risk for alcohol-attributable deaths for the group with 
lowest socioeconomic status compared to the highest. 
This increase in risk is over and above the general 
increased risk of death from all causes in lower socioe-
conomic groups. 
Again, the reasons for these differences in alco-
hol-attributable deaths are not clear. Differences in 
consumption patterns have not been able to explain 
the difference and combination effects with smoking, 
e.g. mouth cancer, represent only a small part of the 
number of deaths. Access to primary care and dietary 
differences can be possible factors.
All alcohol-attributable harm is in principle avoidable. 
In Europe almost 14 per cent of all deaths in adult men 
and 8 per cent in adult women (aged 15–64 years) are 
estimated as attributable to alcohol. General alcohol 
policy measures like taxation, limitation of selling 
times and density of alcohol stores have been shown 
to be effective to reduce socioeconomic differences 
in alcohol-related harm. Social welfare spending 
has also been shown to reduce alcohol-attributable 
deaths, whereas rising health care spending was not. 
Nevertheless, screening and brief intervention in 
primary health care have been shown to be cost-effec-
tive measures to reduce alcohol consumption, related 
harm and mortality.
REFERENCE
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ALCOHOL AND ALCOHOL 
RELATED HARM IN CHINA
China is the world’s most populous 
country. With its 1.35 billion inhabitants 
it represents almost one fifth of the 
world’s population. The growing consump-
tion of alcohol in China and its subse-
quent harm, as well as policy response, is 
described in an article in the Bulletin of 
the World Health Organisation.
Drinking alcohol has been traditional in China during 
major social events, such as the spring festival and 
wedding ceremonies. However, the rapid growth in the 
Chinese economy has been accompanied by notice-
able changes in the drinking behaviour of the Chinese 
population.
Alcohol consumption in China is increasing faster than 
anywhere else in the world. Alcohol consumption per 
capita 15 years of age and older is estimated to have 
increased from 0.4 litres of pure alcohol in 1952 to 
2.5 litres at the end of the Cultural Revolution in 1978 
and to 4.9 litres in 2009. This figure does not include 
unregistered consumption which for the year 2000 was 
estimated to 1.7 litres per capita, approximately 30 per 
cent of total consumption.
A national survey of drinking in China for the year 
2007 revealed that 55.6% of the men and 15.0% of the 
women were current drinkers, of which 62.7% of the 
men and 51.0% of the women reported excessive drin-
king. That would imply that e.g. more than 200 million 
Chinese men drink excessively.
Alcohol-related harm has not been systematically 
studied in China and reliable, nation-wide data are 
not available. According to World Health Organization 
estimates, rates of alcohol use disorders in China are 
6.9% and 0.2% among men and women, respectively, 
corresponding to more than 26 million persons. 
As in other countries, alcohol drinking is associated 
not just with health-related harm, but also with social 
harm, specifically traffic accidents, crime and child 
abuse, domestic violence and injuries of all types, 
including work-related injuries. The data are sparse 
however and most studies are based on case analysis or 
small clinical samples.
Alcohol policies in China are weak. For example, 
China has no enforceable legal drinking age and does 
not regulate when or where alcoholic products are 
sold. Weak alcohol policies lead to increased alcohol 
consumption and alcohol-related problems. Few things 
can be accomplished in China without the direct invol-
vement and support of the central government. Unlike 
the use of tobacco and illicit drugs, alcohol use has 
received scant attention from Chinese policy-makers 
and public health officials. Some of them even argue 
that the alcohol industry is an important driver of 
national economic growth. Hence, China’s government 
agencies for alcohol regulation are poorly coordinated. 
Several ministries share responsibility for different 
aspects of alcohol policy and no national supervisory or 
coordinating body exist.
The authors recommend that China’s government offi-
cials follow WHO’s Global alcohol strategy as a model 
for the planning and implementation of a public health 
approach to alcohol control. Many of the interventions 
in the strategy are universal measures intended to 
reduce the affordability by strengthening taxation, 
availability by licensing of sales or creating state retail 
monopolies for alcohol and accessibility of alcohol, e.g. 
by enforcing age controls and marketing restrictions. 
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DOES THE ALCOHOL POLICY 
ENVIRONMENT HAVE ANY 
EFFECT ON THOSE WHO 
DRINK EXCESSIVELY?
Most evaluation of alcohol policies look to changes in 
individual policies and relate those to level of consump-
tion and harm. But the combined effect of several 
policies and the importance of the degree of imple-
mentation have received less attention from research. 
One earlier study has created an Alcohol Policy Index, 
taking into account both efficacy and stringency of 
implementation. The index was used across 30 OECD 
states and compared to per capita alcohol consumption 
as well as youth drinking. 
A study published in American Journal of Preventive 
Medicine 2014, constructs a scale of alcohol policies 
across United States and correlates it to the level of 
excessive drinking, i.e. binge drinking or drinking 
above estimated levels of low-risk drinking. 
Excessive drinking is a leading cause of disease, death, 
social problems, and economic costs in the U.S. Binge 
drinking alone accounts for approximately half of alco-
hol-attributable deaths, two thirds of years of potential 
life lost, and three fourths of economic costs.
For the study ten alcohol policy experts nominated 
policies to be included. Forty-seven policies were nomi-
nated and 29 were eventually selected for ratings of effi-
cacy and implementation. As the aim was to study state 
policy environments, federal policies or those that did 
not vary across states or did not exist in the U.S. were 
excluded. Examples of excluded policies were blood 
alcohol concentration (BAC) 0.05 laws that do not exist 
in the U.S. and restrictions on mass media advertising 
which are not promulgated at the state level.
The Alcohol Policy Score, taking into account both 
efficacy and implementation of each of the included 
29 policies, was constructed for each state and year. A 
higher score, i.e. more stringent alcohol policy environ-
ment, was associated with lower rate of excessive 
alcohol consumption. 
A following study evaluated the effect of different cate-
gories of policies on binge drinking in the U.S. It found 
that policies that targeted the general population rather 
than the underage population, alcohol consumption 
rather than impaired driving, and raising the price or 
reducing the availability of alcohol had the strongest 
independent associations with reduced binge drinking. 
Alcohol taxes and outlet density accounted for approxi- 
mately half of the magnitude observed for all policies.
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ARE ALCOHOL POLCIES 
EFFECTIVE IN LOW- 
AND MIDDLE-INCOME 
COUNTRIES?
Most of the research on alcohol policies has been 
conducted in high-income, western countries. This 
raises the question whether the policies like taxes, 
limited availability, marketing restrictions etc. are 
effective also in low- and middle-income countries. 
Lower living standards and different drinking cultures 
could conceivably change the effect of alcohol policies.
Data on alcohol consumption and policies from 15 
low- and middle-income countries between 1998 and 
2005 were compared in a study published 2014. The 
countries were mainly South American, African and 
Asian countries.
The analysis shows that policies that limit the physical 
availability or raise prices are effective also in these 
countries. For physical availability, policies that limit 
business hours or involve a licensing system for off-pre-
mises alcohol retail sales, as well as minimum legal 
drinking age, were the policies that most consistent 
lowered alcohol consumption. Higher alcohol price 
levels were also associated with lower drinking. Greater 
restrictions on alcohol advertising, particularly beer 
advertising, were also associated with lower alcohol 
consumption. However, policies that set legal blood 
alcohol concentration limits for drivers and random 
breath testing to enforce the limits were not associated 
significantly with alcohol consumption. 
The authors conclude: 
“Expansion of industrial production and marketing 
of alcohol is driving alcohol use to rise in emerging 
markets; cost-effective and affordable interventions to 
restrict alcohol-related harm exist, and are in urgent 
need of scaling up. With few civic organizations being 
present whose mandate is to reduce alcohol-related 
harms, there has been a lack of non-governmental 
organization engagement, while alcohol-industry 
funded organizations have promoted a ‘partnership’ 
role with governments to design national alcohol 
policies, as observed in some low-income countries. 
There is a need to develop public health infrastructures 
in those countries to develop, enact and then enforce 
comprehensive alcohol policies.”
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UNDER THE INFLUENCE –  
AN INVESTIGATION INTO THE DEBATE 
ON MINIMUM PRICING FOR 
ALCOHOL IN ENGLAND
In March 2012 the British conservative prime minister, 
David Cameron, announced the government’s decision 
to introduce a minimum price for a unit of alcohol. This 
would help reduce drinking in those who drink the 
most and a minimum price of 40 pence (approximately 
5 Swedish kr), could mean 50 000 fewer crimes and 
900 fewer alcohol-related deaths a year, according to 
the government. The prime minister acknowledged that 
the proposal wouldn’t be universally popular, but said 
that “the responsibility of being in government isn’t 
always about doing the popular thing. It’s about doing 
the right thing.”
A year later, in an extraordinary U-turn, the govern-
ment announced that it had scrapped the proposal. The 
background to these events, the scientific evaluations 
and the lobbying efforts of the British alcohol industry, 
is described in a series of articles published in 2014, 
commissioned by British Medical Journal, BMJ, and 
written by the freelance journalist Jonathan Gornall.
The process started in 2008 when the Labour govern-
ment commissioned a report from a research group at 
Sheffield University on the effect of different alcohol 
policy options, among them taxes and minimum 
prices. The results showed that an increase in level of 
minimum pricing would be followed by steep in- 
creases in reduction of harm. A 40p minimum price 
would reduce overall consumption by 2.6%, while 50p 
would cause a 6.9% drop in consumption. That popu-
lation-wide measures, like general increases in prices, 
are the most effective to reduce harm is well known 
from research and the British Medical Association 
stated in a submission to the British government that 
“Measures need to be taken to reduce the mean level of 
consumption within the UK, as it is clear that the lower 
the mean level of consumption the fewer problems 
associated with alcohol, both for the individual and for 
society.”
This is disapproved by the alcohol industry as such 
measures are potentially damaging to the companies’ 
profits. In the industry campaign several reports from 
right-wing think-tanks were used. E.g. the Adam Smith 
Institute report “Minimal evidence for minimum 
pricing” declared that the Sheffield report was “enti-
rely speculative and do not deserve the exalted status 
they have been afforded in the policy debate.” The 
brewer SABMilller commissioned another report from 
the think tank 
The Centre for 
Economics 
and Business 
Research 
stating that 
minimum 
prices would make 
little difference to harm from 
alcohol misuse but increase the 
financial burden of moderate 
drinkers on low incomes. With 
the help of another report 
from the same think-tank, 
the Wine and Spirit Trade 
Association tried to cast 
doubts on the results from 
Sheffield University and laun-
ched a campaign with the message “Why should 
responsible drinkers pay more?” 
This was combined with intense contacts from the 
industry with individual members of Parliament and 
governments departments. While the public health 
community had difficulties getting access to govern-
ment officials for meetings industry representatives had 
almost daily contact with government departments. 
Jim McCambridge, researcher at the London School of 
Hygiene and Tropical Medicine have interviewed senior 
members of the industry for a study examining influ-
ence on health policy found that the industry lobbying 
was really about building long term relationships with 
key policy actors so influence can be exerted in very 
subtle ways and within these long term relationships 
you see quite astonishing levels of contact.
Strategies to counter demands for regulations were 
discussed within the alcohol industry as much as 30 
years ago. In 1984 a senior executive in one of the 
drinks giants of the time, Grand Metropolitan, circu-
lated a confidential memo where he proposed that the 
alcohol industry should learn from the mistakes of 
the tobacco industry. He wrote that “special interest 
groups” drew attention to the problems of alcohol abuse 
and demanding increased restrictions as higher taxes, 
restrictions on retail hours, advertising and marketing 
restrictions, and health warning and ingredient labels 
on drinks. The alcohol industry should instead promote 
the position that alcohol in moderation is good for the 
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consumer but in excess it is bad and he warned that if 
the media would concentrate on the harm of alcohol 
“voters will come to believe that alcohol is bad and the 
drinks industry irresponsible.”
One way of achieving long term relations between 
political representatives and the alcohol industry are 
the all party groups in the British parliament. There are 
four such groups supporting and funded by the alcohol 
industry, for beer, for wine and spirits, for Scotch 
whisky and for cider. In total there are 472 all party 
groups in the parliament but the largest is the beer 
group with 300 MPs as members, almost half of all in 
the House of Commons, and 100 members from the 
House of Lords. 
There is a big difference in resources and access to 
contacts with the public health community. John 
Holmes of Sheffield University’s alcohol research unit, 
states that such groups “allow industry actors to . . . talk 
to lots of MPs in a way that just wouldn’t be available to 
any public health group.” Another disadvantage for the 
scientists is that the think tanks and the alcohol indu-
stry representatives are not really interested in whether 
their arguments are accurate or not. “It’s all about crea-
ting doubt about what we’re saying”, say Holmes. 
As a conclusion of the article series, Jonathan Gornall 
wrote “Five years on—and, by the government’s esti-
mate, hundreds if not thousands of avoidable deaths 
later— … thanks to a combination of political self 
interest, libertarian ideology, and industry’s unfettered 
ability to lobby the length and breadth of Westminster, 
‘big alcohol’ had won the day.”
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DOES REDUCTION IN  
DRINKING REDUCE RISK OF 
DEATH FOR  
INDIVIDUALS WITH ALCOHOL 
USE DISORDERS?
Alcohol use disorder is a medical diagnosis covering 
biological aspects, as tolerance to alcohol, withdrawal 
symptoms, psychological, like loss of control and beha-
vioural aspects, as reduced occupational and recrea-
tional pursuits. Alcohol use disorders are among the 
most common mental disorders globally. In Europe it 
is the second largest mental disorder after depression, 
responsible for 6.2 per cent of all years lived with disabi-
lity from chronic conditions. 
A study summarizing 16 articles on cohort studies, i.e. 
groups of individuals that are followed several years, of 
persons with diagnosed with alcohol use disorders found 
that those who reduced their drinking reduced their risk 
of death substantially, compared to those who conti-
nued with heavy drinking. The studies were from USA, 
Europe, Sri Lanka and Japan. The mean time of follow 
up was almost nine years. 
For those who reached abstention the risk of death was 
35 per cent of the risk of death for those who continued 
heavy drinking. For those who substantially reduced 
their drinking without reaching abstention the risk of 
death was 61 per cent. Taken together the reduction in 
mortality was marked. Those who reduced their drink- 
ing had less than half the risk of those who continued 
their heavy drinking. Seen from the other perspective, 
people with continued heavy drinking had more than 
double the risk of death. 
This result coincides with the results from studies on 
other and general populations. A reduction in alcohol 
consumption has been shown to result in a reduction of 
mortality in both aggregate-level and individual-level 
studies. People with alcohol use disorders also die from 
causes that are common in the general population, such 
as injury, heart disease, liver cirrhosis and cancer. The 
authors conclude that “while the magnitude of mortality 
reductions found in our meta-analysis may be specific to 
people with AUD [alcohol use disorders] from inpatient 
treatment settings, the underlying biological mecha-
nisms may apply to other population groups”.
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DOES ALCOHOL  
PRODUCTION AND 
CONSUMPTION INCREASE 
ECONOMIC GROWTH?
The production and sale of alcohol creates jobs in the 
alcohol trade and create revenue for the companies 
involved. It is therefore easy to imagine that the sale 
of alcohol is positive for the economy and economic 
growth. This is often stated by alcohol producers saying 
that the industry is a major contributor to the economy 
through job creation, wages and taxes. But a study from 
the US shows that this may not always be the case. For 
the economy as a whole, decreasing alcohol consump-
tion, e.g. following an increase in taxes, increased 
total economic growth in the US during the period of 
study. This is the first study on the relation of alcohol 
consumption and total economic growth.
Labour productivity is one of the most important deter-
minants of economic growth. Alcohol consumption 
lowers productivity in different ways. Drinking-related 
lost workdays can result from sickness absences, 
driving under the influence (DUI) arrests, alcohol-re-
lated injury work leaves, incarcerations due to alco-
hol-induced criminal activity, and alcohol-dependen-
ce-related withdrawals from the labour force. Several 
studies also show a direct association between alcohol 
use and reduced workplace performance measured 
through absenteeism, poor relations with co-workers, 
and accidents.
The importance of alcohol use for disease is also well 
documented. This includes injuries as well as chronic 
diseases and sexually transmitted infections. Diseases 
reduce the returns to human capital by lowering 
labour productivity as well as increasing lost workdays. 
Studies from different parts of the world show that 
alcohol use is costly to societies.
The US study used data from US states for the period 
1971–2007, relating alcohol use to per capita gross 
domestic product (GDP) growth. The study focused 
on beer consumption as beer is the major source of 
alcohol consumption in the United States, making up 
approximately 55% of total alcohol consumption. Beer 
sales were therefore used as an indicator for alcohol 
consumption. When the researchers looked at total 
alcohol sales and economic growth the results were 
similar to those on per capita beer use. 
The result for the study period is that a decrease in per 
capita consumption of one litre beer was associated 
with an increase of GDP growth of 1.7 per cent. An 
increase of beer tax, which lowers consumption, was 
hence associated to increase in economic growth. 
When looking at cigarette excise tax rate the study 
found strong relation to per capita cigarette consump-
tion, but this did not have a significant impact on 
economic growth, possibly for the reason that smok-
ing-induced costs have a much smaller effect on 
economic productivity than drinking.
The authors conclude that “the aggregate costs of the 
“bar tab” are indeed borne by society as a whole” and 
“Our results do, contrary to the claims of the Distilled 
Spirits Council and Beer Serves America, suggest that 
alcohol excise taxes do not harm economic activity at 
the aggregate level. If anything, our results show that 
beer excise tax rates are directly linked to economic 
growth.”
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